How can you determine the culprit lesion in NSTEMI?

PCR Perspectives

Summary

Since patients with NSTEMI represent an important population in practice, Ziad Ali and Natalia Pinilla discuss the diagnosis of culprit lesions in such patients. The first tool to rely on is intravascular imaging, even if imaging does not yet allow the interpretation of ambiguous or residual lesions. They also discuss how the OCT sub-study of the COMPLETE trial provides valuable answers to practitioners.